Loans Held for Investment and Loans Held for Investment at Fair Value | Note 6 — Loans Held for Investment and Loans Held for Investment at Fair Value The following tables summarize loans held for investment as of June 30, 2020 and December 31, 2019 (in thousands): June 30, 2020 December 31, 2019 Loans held for investment, net Loans held for investment, at fair value Total loans held for investment Total loans held for investment Unpaid principal balance $ 1,841,238 $ 3,369 $ 1,844,607 $ 1,843,290 Valuation adjustments on FVO loans — (413 ) (413 ) (444 ) Deferred loan origination costs 25,801 — 25,801 25,714 1,867,039 2,956 1,869,995 1,868,560 Allowance for loan losses (5,220 ) — (5,220 ) (2,240 ) Total loans held for investment and loans held for investment at fair value, net $ 1,861,819 $ 2,956 $ 1,864,775 $ 1,866,320 As of June 30, 2020, $293.7 million of loans held for investment have participated in the COVID-19 forbearance program. Accrued interest on these loans was $11.6 million as of June 30, 2020. As of June 30, 2020 and December 31, 2019, the gross unpaid principal balance of loans held for investment pledged as collateral for the Company’s warehouse facility agreements, and securitizations issued were as follows (in thousands): June 30, 2020 December 31, 2019 Citibank warehouse repurchase agreement $ 148,272 $ 108,504 Barclays warehouse repurchase agreement 120,498 175,689 Pacific Western Bank agreement — 3,331 Total pledged loans $ 268,770 $ 287,524 2014-1 Trust 26,124 29,559 2015-1 Trust 59,168 64,876 2016-1 Trust 82,693 97,727 2016-2 Trust 56,517 68,961 2017-1 Trust 95,491 116,670 2017-2 Trust 157,558 173,390 2018-1 Trust 129,111 141,567 2018-2 Trust 239,362 260,278 2019-1 Trust 218,681 229,151 2019-2 Trust 193,185 210,312 2019-3 Trust 146,479 157,119 2020-1 Trust 256,683 — 2020-2 Trust 128,207 Total $ 1,789,259 $ 1,549,610 (a) Nonaccrual The following tables present the amortized cost basis, or recorded investment, of the Company’s loans held for investment that were nonperforming and on nonaccrual status as of June 30, 2020 and December 31, 2019, and accruing loans that were 90 days or more past due as of June 30, 2020 under the Company’s COVID-19 payment deferral programs. There were no loans accruing interest that were greater than 90 days past due as of December 31, 2019. June 30, 2020 Nonaccrual With Loans 90+ DPD No Allowance Total Still Accruing for Loan Loss Nonaccrual COVID-19 Program (In thousands) Commercial - Purchase $ 19,269 $ 20,615 $ 18,798 Commercial - Refinance 109,897 113,350 54,323 Residential 1-4 Unit - Purchase 21,760 22,017 14,603 Residential 1-4 Unit - Refinance 109,005 114,790 36,264 Total $ 259,931 $ 270,772 $ 123,988 Troubled Debt Restructuring included in nonaccrual loans: $ — $ 175 $ — December 31, 2019 ($ in thousands) Nonaccrual loans: Recorded investment $ 125,819 Percentage of the originated loans held for investment 6.7 % Impaired loans: Unpaid principal balance $ 124,050 Recorded investment 125,998 Recorded investment of impaired loans requiring a specific allowance 12,286 Specific allowance 913 Specific allowance as a percentage of recorded investment of impaired loans requiring a specific allowance 7.4 % Recorded investment of impaired loans not requiring a specific allowance $ 113,712 Percentage of recorded investment of impaired loans not requiring a specific allowance 90.2 % TDRs included in impaired loans: Recorded investment of TDRs $ 179 Recorded investment of TDRs with a specific allowance 179 Specific allowance 25 Recorded investment of TDRs without a specific allowance — The Company has made the accounting policy election not to measure an allowance for credit losses for accrued interest receivables. The Company has also made the accounting policy election to write off accrued interest receivables by reversing interest income when loans are placed on nonaccrual status, or 90 days or more past due, other than the COVID-19 forbearance-granted loans. The Company will continue to evaluate the COVID-19 forbearance-granted loans on an individual basis to determine if a reserve should be established on the collectability of the accrued interest and whether any loans should be placed on nonaccrual status at a future date. The following table presents the amortized cost basis in the loans held for investment as of June 30, 2020 and 2019, and the amount of accrued interest receivables written off by reversing interest income by portfolio segment for the six months ended June 30, 2020 and 2019 (in thousands): June 30, 2020 June 30, 2019 Amortized Cost Interest Reversal Amortized Cost Interest Reversal Commercial - Purchase $ 303,373 $ 425 $ 255,802 $ 119 Commercial - Refinance 711,397 2,633 $ 647,838 558 Residential 1-4 Unit - Purchase 245,579 404 $ 237,445 154 Residential 1-4 Unit - Refinance 606,432 2,255 $ 544,663 499 Total $ 1,866,781 $ 5,717 $ 1,685,748 $ 1,330 For the six months ended June 30, 2020 and 2019, there was no accrued interest income recognized on nonaccrual loans, cash basis interest income recognized on nonaccrual loans was $6.7 million and $5.4 million, respectively, and the average recorded investment of individually evaluated loans, computed using month-end balances, was $180.2 million and $105.2 million, respectively. There were no commitments to lend additional funds to debtors whose loans have been modified as of June 30, 2020 and December 31, 2019. (b) Allowance for Credit Losses The following tables present the activity in the allowance for credit losses for the three and six months ended June 30, 2020 and 2019 (in thousands): Three Months Ended June 30, 2020 2019 Residential Residential Commercial Commercial 1-4 Unit 1-4 Unit Purchase Refinance Purchase Refinance Total Total Allowance for credit losses: Beginning balance $ 352 $ 1,594 $ 250 $ 1,300 $ 3,496 $ 1,916 Provision for loan losses 172 1,093 211 324 1,800 212 Charge-offs — — (58 ) (18 ) (76 ) (32 ) Ending balance $ 524 $ 2,687 $ 403 $ 1,606 $ 5,220 $ 2,096 Six Months Ended June 30, 2020 2019 Residential Residential Commercial Commercial 1-4 Unit 1-4 Unit Purchase Refinance Purchase Refinance Total Total Allowance for credit losses: Beginning balance, prior to adoption of ASC 326 $ 304 $ 1,016 $ 148 $ 772 $ 2,240 $ 1,680 Impact of adopting ASC 326 19 62 9 47 137 — Provision for loan losses 280 1,609 382 817 3,088 560 Charge-offs (79 ) — (136 ) (30 ) (245 ) (144 ) Ending balance $ 524 $ 2,687 $ 403 $ 1,606 $ 5,220 $ 2,096 Allowance related to: Loans individually evaluated $ 181 $ 592 $ 96 $ 404 $ 1,273 $ 803 Loans collectively evaluated 342 2,095 307 1,203 3,947 1,293 Amortized cost related to: Loans individually evaluated $ 20,615 $ 113,350 $ 22,017 $ 114,790 $ 270,772 $ 99,905 Loans collectively evaluated 282,759 598,046 223,561 491,643 1,596,009 1,585,843 (c) Credit Quality A credit quality indicator is a statistic used by the Company to monitor and assess the credit quality of loans held for investment, excluding loans held for investment at fair value. The Company monitors its charge-off rate in relation to its nonperforming loans as its credit quality indicator. Nonperforming loans are loans that are 90 or more days past due, in bankruptcy, in foreclosure, or not accruing interest. For the three months ended June 30, 2020, the annualized charge-off rate was 0.1%of average nonperforming loans. The charged-off rate was 0.52% for the year ended December 31, 2019. Other credit quality indicators include aging status and accrual status. The following table presents the aging status of the amortized cost basis in the loans held for investment portfolio as of June 30, 2020, which includes $293.7 million loans in the Company’s COVID-19 forbearance program, and as of December 31, 2019 (in thousands): 30–59 days 60–89 days 90+days Total Total June 30, 2020 past due past due past due ( 1) past due Current loans Loans individually evaluated Commercial - Purchase $ 256 $ 2,346 $ 18,013 $ 20,615 $ — $ 20,615 Commercial - Refinance 6,349 3,957 102,869 113,175 175 113,350 Residential 1-4 Unit - Purchase — 193 21,824 22,017 — 22,017 Residential 1-4 Unit - Refinance 2,122 3,741 108,927 114,790 — 114,790 Total loans individually evaluated $ 8,727 $ 10,237 $ 251,633 $ 270,597 $ 175 $ 270,772 Loans collectively evaluated Commercial - Purchase $ 20,880 $ 21,454 $ 18,798 $ 61,132 $ 221,626 $ 282,758 Commercial - Refinance 42,512 57,863 54,323 154,698 443,349 598,047 Residential 1-4 Unit - Purchase 16,377 17,571 14,603.0 48,551 175,011 223,562 Residential 1-4 Unit - Refinance 43,251 51,319 36,264.0 130,834 360,808 491,642 Total loans collectively evaluated $ 123,020 $ 148,207 $ 123,988 $ 395,215 $ 1,200,794 $ 1,596,009 Ending balance $ 131,747 $ 158,444 $ 375,621 $ 665,812 $ 1,200,969 $ 1,866,781 December 31, 2019: Impaired loans $ 6,195 $ 7,696 $ 111,928 $ 125,819 $ 179 $ 125,998 Nonimpaired loans 119,465 41,138 — 160,603 1,578,984 1,739,587 Ending balance $ 125,660 $ 48,834 $ 111,928 $ 286,422 $ 1,579,163 $ 1,865,585 (1) Includes loans in bankruptcy and foreclosure less than 90 days past The following table presents the aging of the amortized cost basis of loans held for investment in the Company's COVID-19 forbearance program as of June 30, 2020 (in thousands): 30–59 days 60–89 days 90+days Total Total June 30, 2020 past due past due past due ( 1) past due Current loans Loans individually evaluated Commercial - Purchase $ — $ 607 $ 493 $ 1,100 $ — $ 1,100 Commercial - Refinance 2,143 2,659 5,938 10,740 — 10,740 Residential 1-4 Unit - Purchase — — — — — — Residential 1-4 Unit - Refinance — 677 6,935 7,612 — 7,612 Total loans individually evaluated $ 2,143 $ 3,943 $ 13,366 $ 19,452 $ — $ 19,452 Loans collectively evaluated Commercial - Purchase $ 6,397 $ 18,220 $ 18,798 $ 43,415 $ 1,357 $ 44,772 Commercial - Refinance 14,932 39,382 54,323 108,637 5,128 113,765 Residential 1-4 Unit - Purchase 4,447 12,957 14,603.0 32,007 504 32,511 Residential 1-4 Unit - Refinance 11,607 30,649 36,264.0 78,520 4,718 83,238 Total loans collectively evaluated $ 37,383 $ 101,208 $ 123,988 $ 262,579 $ 11,707 $ 274,286 Ending balance $ 39,526 $ 105,151 $ 137,354 $ 282,031 $ 11,707 $ 293,738 (1) Includes loans in bankruptcy and foreclosure less than 90 days past In addition to the aging status, the Company also evaluates credit quality by accrual status. The following table presents the amortized cost in loans held for investment, excluding loans held for investment at fair value, based on accrual status and by loan origination year. Term Loans Amortized Cost Basis by Origination Year June 30, 2020: 2020 2019 2018 2017 2016 Pre-2016 Total Commercial - Purchase Payment performance Performing $ 34,584 $ 108,737 $ 69,533 $ 43,403 $ 12,436 $ 14,065 $ 282,758 Nonperforming 1,248 2,311 7,556 5,455 1,638 2,407 20,615 Total Commercial - Purchase $ 35,832 $ 111,048 $ 77,089 $ 48,858 $ 14,074 $ 16,472 $ 303,373 Commercial - Refinance Payment performance Performing $ 47,092 $ 189,377 $ 162,485 $ 97,438 $ 41,402 $ 60,253 $ 598,047 Nonperforming 4,329 24,968 36,661 26,465 8,234 12,693 113,350 Total Commercial - Refinance $ 51,421 $ 214,345 $ 199,146 $ 123,903 $ 49,636 $ 72,946 $ 711,397 Residential 1-4 Unit - Purchase Payment performance Performing $ 17,197 $ 79,654 $ 52,571 $ 33,293 $ 9,076 $ 31,771 $ 223,562 Nonperforming — 6,057 6,715 4,355 1,348 3,542 22,017 Total Residential 1-4 Unit - Purchase $ 17,197 $ 85,711 $ 59,286 $ 37,648 $ 10,424 $ 35,313 $ 245,579 Residential 1-4 Unit - Refinance Payment performance Performing $ 45,449 $ 194,144 $ 106,217 $ 73,069 $ 28,540 $ 44,223 $ 491,642 Nonperforming 3,206 35,013 37,479 16,467 7,400 15,225 114,790 Total Residential 1-4 Unit - Purchase $ 48,655 $ 229,157 $ 143,696 $ 89,536 $ 35,940 $ 59,448 $ 606,432 Total Portfolio $ 153,105 $ 640,261 $ 479,217 $ 299,945 $ 110,074 $ 184,179 $ 1,866,781 |